Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients

BACKGROUND: Cysteinyl leukotrienes (CysLT) are potent inflammation-promoting mediators, but remain scarcely explored in COVID-19. We evaluated urinary CysLT (U-CysLT) relationship with disease severity and their usefulness for prognostication in hospitalized COVID-19 patients. The impact on U-CysLT...

Descripción completa

Detalles Bibliográficos
Autores principales: Reina-Couto, Marta, Roboredo-Madeira, Mariana, Pereira-Terra, Patrícia, Silva-Pereira, Carolina, Martins, Sandra, Teixeira-Santos, Luísa, Pinho, Dora, Dias, Andreia, Cordeiro, Gonçalo, Dias, Cláudia Camila, Sarmento, António, Tavares, Margarida, Guimarães, João T., Roncon-Albuquerque, Roberto, Paiva, José-Artur, Albino-Teixeira, António, Sousa, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826622/
https://www.ncbi.nlm.nih.gov/pubmed/36617343
http://dx.doi.org/10.1007/s00011-022-01682-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826622/
https://www.ncbi.nlm.nih.gov/pubmed/36617343
http://dx.doi.org/10.1007/s00011-022-01682-z

Ejemplares similares